ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Indian patent office grants patent to Pfizer for Prevnar 13
August 23, 2017The granting of this patent would block other manufacturers in India from supplying this vaccine -
Which M&A made our best-and-worst ballot? Vote for the deals of the decade
August 16, 2017Choose among 20-plus deals—big, like the GSK-Novartis asset swap, and smaller buys such as Bristol-Myers' Medarex buyout—for best and worst of the past 10 years. -
EC approves Pfizer’s acute lymphoblastic leukemia treatment Besponsa
July 05, 2017The European Commission (EC) has approved Pfizer’s Besponsa (inotuzumab ozogamicin) for the treatment of adults with relapsed or refractory CD22-positive B-cell precursor acute lymphoblastic leukaemia (ALL) in the European Union (EU). -
Roche, Pfizer and Aspen under investigation over cancer drug pricing
June 21, 2017The Competition Commission of South Africa has initiated separate investigations against three global pharmaceutical companies over suspected excessive pricing of cancer medicines.
Pharma Sources Insight January 2025
